Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539000 of 542236 entries
View as:

Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT03364920 Org: User:
Start: 01/01/18 End: 01/01/20 Due: 01/01/21

Segmental Mechanisms of Transcutaneous Spinal Cord Stimulation for Spasticity Control

Phase: N/A Priority: Normal
NCT ID: NCT03886857 Org: User:
Start: 05/01/19 End: 10/01/22 Due: 10/01/23

The Effect of Umbilical Cord Clamping Distance

Phase: N/A Priority: Normal
NCT ID: NCT04862403 Org: User:
Start: 06/01/18 End: 03/30/19 Due: 03/30/20

TASALL - TachoSil® Against Liquor Leak

Phase: N/A Priority: Normal
NCT ID: NCT01355627 Org: User:
Start: 04/30/11 End: 06/30/13 Due: 06/30/14

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

Phase: N/A Priority: Normal
NCT ID: NCT04305756 Org: User:
Start: 06/12/20 End: 12/15/21 Due: 12/15/22

Breast Cancer Genome Guided Therapy Study (BEAUTY)

Phase: N/A Priority: Normal
NCT ID: NCT02022202 Org: User:
Start: 02/28/13 End: 12/14/32 Due: 12/14/33

SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03161262 Org: User:
Start: 06/09/17 End: 03/01/19 Due: 03/01/20

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02769481 Org: User:
Start: 08/15/16 End: 06/14/19 Due: 06/14/20

Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.

Phase: N/A Priority: Normal
NCT ID: NCT02496312 Org: User:
Start: 07/10/15 End: 10/02/15 Due: 10/02/16

South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00121966 Org: User:
Start: 01/31/03 End: 07/31/07 Due: 07/31/08

Study Assessing the Safety and Performance of Smart Matrix®

Phase: N/A Priority: Normal
NCT ID: NCT03742726 Org: User:
Start: 10/12/18 End: 01/31/22 Due: 01/31/23

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03510715 Org: User:
Start: 08/31/18 End: 02/17/20 Due: 02/17/21

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT00561379 Org: User:
Start: 04/30/05 End: 05/31/13 Due: 05/31/14

Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02184286 Org: User:
Start: 05/31/99 End: - Due: -

Facilitated Tucking Position and Reiki Efficacy in Orogastric Tube Insertion

Phase: N/A Priority: Normal
NCT ID: NCT05801640 Org: User:
Start: 02/01/22 End: 01/15/23 Due: 01/15/24

Evaluation of the Efficacy of a Coordinated Interprofessional Care Pathway on Disability in Patients With Chronic and at Risk of Chronic Low Back Pain in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT05531201 Org: User:
Start: 02/15/23 End: 11/13/26 Due: 11/13/27

Fetoscopic Endoluminal Tracheal Occlusion (FETO) with Smart-TO

Phase: N/A Priority: Normal
NCT ID: NCT04931212 Org: User:
Start: 08/04/21 End: 09/05/24 Due: 09/05/25

A.L.P.S. Clavicle Plating System PMCF

Phase: N/A Priority: Normal
NCT ID: NCT05327959 Org: User:
Start: 05/13/22 End: 03/31/27 Due: 03/31/28

Hub-Based Engagement Navigator Service to Reduce CSC Disengagement

Phase: N/A Priority: Normal
NCT ID: NCT06583239 Org: User:
Start: 09/10/25 End: 07/31/29 Due: 07/31/30

Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT03844607 Org: User:
Start: 01/08/19 End: 01/01/25 Due: 01/01/26

Post Marketing Surveillance of Roflumilast in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02068456 Org: User:
Start: 09/18/12 End: 04/26/17 Due: 04/26/18

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02806973 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

Recognition and Treatment of Dysglycemia. AGS - Acute Glucose Service

Phase: N/A Priority: Normal
NCT ID: NCT03306810 Org: User:
Start: 09/26/17 End: 12/31/25 Due: 12/31/26

Reducing Disparity in Receipt of Mother's Own Milk in Very Low Birth Weight Infants

Phase: N/A Priority: Normal
NCT ID: NCT04540575 Org: User:
Start: 12/03/20 End: 12/31/25 Due: 12/31/26

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04251715 Org: User:
Start: 04/28/21 End: 11/30/25 Due: 11/30/26